HLA Typing for Transplant Market Report: Trends, Forecast and Competitive Analysis to 2030

HLA Typing for Transplant Trends and Forecast

The future of the global HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets. The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

A more than 150-page report is developed to help in your business decisions.

HLA Typing for Transplant by Segment

The study includes a forecast for the global HLA typing for transplant by product type, technology, application, end use industry, and region.

HLA Typing for Transplant Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Reagents and Consumables
• Instruments
• Software and Services

HLA Typing for Transplant Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Molecular Assay Technologies
• Non- Molecular Assay Technologies

HLA Typing for Transplant Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic
• Research
• Others

HLA Typing for Transplant Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Independent Reference Laboratories
• Hospitals and Transplant Centres
• Research Laboratories and Academic Institutes
• Others

HLA Typing for Transplant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HLA Typing for Transplant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HLA typing for transplant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HLA typing for transplant companies profiled in this report include-

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Qiagen
• Omixon
• GenDx
• Illumina
• TBG Diagnostics
• Dickinson
• Takara Bio
• F. Hoffman-La Roche

HLA Typing for Transplant Market Insights

Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Features of the Global HLA Typing for Transplant Market

Market Size Estimates: HLA typing for transplant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HLA typing for transplant market size by various segments, such as by product type, technology, application, end use industry, and region in terms of ($B).

Regional Analysis: HLA typing for transplant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end use industries, and regions for the HLA typing for transplant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HLA typing for transplant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the HLA typing for transplant market size?

Answer: The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030.

Q.2 What is the growth forecast for HLA typing for transplant market?

Answer: The global HLA typing for transplant market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the HLA typing for transplant market?

Answer: The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

Q4. What are the major segments for HLA typing for transplant market?

Answer: The future of the HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets.

Q5. Who are the key HLA typing for transplant market companies?

Answer: Some of the key HLA typing for transplant companies are as follows:

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Qiagen
• Omixon
• GenDx
• Illumina
• TBG Diagnostics
• Dickinson
• Takara Bio
• F. Hoffman-La Roche

Q6. Which HLA typing for transplant market segment will be the largest in future?

Answer: Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

Q7. In HLA typing for transplant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HLA typing for transplant market by product type (reagents and consumables, instruments, and software and services), technology (molecular assay technologies and non- molecular assay technologies), application (diagnostic, research, and others), end use industry (independent reference laboratories, hospitals and transplant centres, research laboratories and academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?